A double blind placebo controlled clinical trial to evaluate the efficacy and safety of Shatavari in Menstrual irregularity
Phase 2
Completed
- Conditions
- Health Condition 1: null- Menstrual irregularity
- Registration Number
- CTRI/2011/06/001804
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Females above the age of 45 with postmenopausal symptoms like hot flashes, night sweats, dry itchy skin, sleep disturbances, irritability, joint pain, anxiety or depression will be included in the study.
Exclusion Criteria
Subjects suffering from serious life threatening disorders or participated in a similar study within past 1 month will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method